Dr. Dominic Anthony Hovsepian, MD

Dr. Hovsepian practices at Surgery Center Palo Alto in Palo Alto, California.

Dr. Hovsepian's NPI, 1154749588, was assigned on April 2, 2014. Dr. Hovsepian graduated from Weill Cornell Medicine in 2014. Dr. Hovsepian holds California license A141089.

Dr. Hovsepian's primary practice is Surgery Center Palo Alto, at 795 El Camino Real, Palo Alto, CA 94301. The practice phone is (650) 324-1832.

Dr. Hovsepian's primary practice is Surgery Center Palo Alto in Palo Alto, California. Dr. Hovsepian is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Hovsepian to 3 more hospitals, 4 medical groups, 2 group practices and clinics and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hovsepian practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hovsepian's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hovsepian is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Hovsepian's licenses on file in 15 states: California, Colorado, Florida, Nevada, Oregon, Wisconsin, Alabama, Idaho, Kansas, Missouri, New Mexico, Texas, Utah, Virginia and Wyoming.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Hovsepian treats.

CMS data shows 521 Medicare services from Dr. Hovsepian across 9 procedure codes in 2024, for 256 Medicare patients. Medicare paid $82,896 for them. Every service was in an office.

CMS counts 256 Medicare patients who saw Dr. Hovsepian in 2024. The largest group is 75 to 84, with 111 patients. 71% of them have high cholesterol, and 61% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hovsepian's median patient age at 62, with 56% women.

In 2024, Dr. Hovsepian wrote 995 Medicare Part D claims for 283 patients. 98% of them were for generic drugs. CMS names the drug for 743 of them, across 22 drugs with 11 or more claims each, at $18,884 in total drug cost. In 2023, CMS named 1,882 claims across 41 drugs.

Dr. Hovsepian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hovsepian as offering telehealth.

Dmand AI links 3 papers to Dr. Hovsepian, published from 2014 to 2021. Dr. Hovsepian's most frequent co-authors are Matthew E. Fink, MD, Hooman Kamel, MD and David Bernard Miklos, MD, PhD.

CMS Open Payments shows 640 general payments to Dr. Hovsepian from 53 drug and device companies from 2020 to 2025. Honoraria make up the largest share, 58% of the total. SK Life Science, Inc. paid the most, $20,491.

Dr. Hovsepian graduated from Weill Cornell Medicine in 2014. Dr. Hovsepian is a member of AAN.

Dr. Hovsepian is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.